2020 Virtual ESMO Review


 

2020 ESMO Update on Non-Hodgkin Lymphomas: Does BETi CC-90010 Lead to Clinical Responses in R/R DLBCL? How Effective Is LSD1 Inhibitor CC-90011 MZL?

17 views
December 3, 2020
Comments 0
Login to view comments. Click here to Login